Navigation Links
Doctors Test Advanced Tool for Treating Prostate Cancer
Date:10/27/2008

Technology Designed to Confirm Precise Brachytherapy Treatment

ST. LOUIS, Oct. 27 /PRNewswire/ -- Leading radiation oncologists are using the TargetScan Touch(TM) system to deliver radioactive seed therapy in the prostate. The innovative technology is based on a motionless probe which stabilizes the prostate during procedures. With the gland stabilized, physicians use a touch-screen interface and 3-D ultrasound images to map and confirm placement of radiation.

Unveiled recently at the 2008 American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting, the TargetScan Touch(TM) has been tested at several of the nation's leading medical centers, including Emory University School of Medicine.

"This technology delivers two important benefits. First, a stabilized prostate; second, the ability to quickly and efficiently image anywhere in the prostate with the point and click function for accurate positioning of radioactivity," explains Peter Rossi, M.D., Emory's assistant professor in the departments of radiation oncology and urology. "TargetScan has a short learning curve for my residents and physicists and has demonstrated its value in that we have consistently achieved quality implants with its help."

Just launched, the system will initially be in clinical use at Emory, Washington University Medical Center in St. Louis, University of Florida and New Hanover Radiation Oncology.

The system is based on the TargetScan(R) technology platform developed by Envisioneering Medical Technologies in St. Louis, under the guidance of physicians at Washington University. "Traditional hand-manipulated devices allow the prostate gland to shift, which impedes placement accuracy. By stabilizing the prostate, physicians can now implant seeds to any and every region of the gland with greater confidence," said Robert Mills, president, Envisioneering Medical Technologies.

Other system features include intuitive imaging and navigational controls and a compact, streamlined system design to enhance treatment efficiency, improve the patient experience and provide ease of transport for physicians managing multiple practice locations.

"The design of TargetScan Touch(TM) is straightforward to support ease of use and widespread adoption so that physicians and their patients can benefit from this new technology," added Mills. "The simplicity of the touch-screen technology saves time while producing detailed images and treatment reports for future patient monitoring."

TargetScan Touch Technical Features:

-- Motionless probe to prevent prostate movement and on-screen image distortion.

-- Mapping technology for complete prostatic coverage, assisting with accurate needle placement to pre-planned cancer targets and preferred treatment zones.

-- 3-D image acquisition to improve visibility, presenting both sagittal and transverse planes with a total viewing volume of 380 mL.

-- Touch-screen technology to improve treatment efficiency and patient experience.

About Envisioneering Medical Technologies

Envisioneering Medical Technologies, based in St. Louis, Mo., is dedicated to creating the standard for prostate cancer care by developing technology for improving prostate cancer diagnosis and treatment precision and effectively managing patients throughout the continuum of care. For more information please visit http://www.envisioneeringmedical.com.


'/>"/>
SOURCE Envisioneering Medical Technologies
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The Doctors Company Launches Litigation Education Retreats to Assist Physicians Involved in Medical Litigation
2. Doctors Lack Smoking Cessation Training
3. Doctors Often Overestimate Patients Health Literacy
4. MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource
5. Research suggests doctors should consider kidney-sparing surgery
6. Will patients stick to physical therapy? Questionnaire can help doctors predict
7. Help for Stutterers on The Doctors TV Show Presented by Power Stuttering Center Founder Mark Power
8. Maternity Care Doctors to Call for Renewal of MCARE Abatement Fund, Address Growing Shortage of Maternity Care Physicians
9. For Some Doctors, Empathy Is in Short Supply
10. Many Doctors Dont Know Blood Pressure Guidelines
11. UC Davis doctors use multimedia to increase colorectal cancer screening among Hispanics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... ... The Margarian Law Firm has filed a class action lawsuit against Dr. ... ginger. Dr. Pepper produces the “Canada Dry” brand of ginger ale products. In Gegham ... Ale claims on its bottle that it is made from real ginger. , When ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Visiting ... the C. R. Bard Foundation, Inc. to support the music therapy ... service available through the nonprofit home care agency. Using evidence-based methods, professionally trained ...
(Date:7/21/2017)... ... July 21, 2017 , ... “Kids aren't born knowing how to regulate ... says Suzanne Tucker, Founder of St. Louis-based positive education company Generation Mindful. To help ... on Monday, July 21st. , The kit uses colorful, engaging and educational illustrations ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased to announce ... Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network of medical ... dermatology, skin cancer , and more. She graduated from the University of Florida ...
(Date:7/21/2017)... ... July 21, 2017 , ... The most ... patients improved quality of life five years after injury, according to research presented ... in Toronto, Ontario, Canada. The study followed patients for five years following surgery. ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... , July 21, 2017  Endo International plc ... completing a comprehensive review of its manufacturing network, the ... and distribution facilities in Huntsville, Alabama ... take place over the next 12 to 18 months. ... impacted by declining volumes of commoditized products and these ...
(Date:7/15/2017)... 2017 Enterin Inc., a Philadelphia ... (PD), today announced the completion of a $12.7 million Series ... III, as well as the participation of existing investors. ... have the support of New Ventures III and our current ... of the potential of our platform technology to transform the ...
(Date:7/13/2017)... -- New York City-based market research firm Kalorama Information notes seven ... From new products to new costs, to the threat of ... study, Potential Pipeline Disruptors . Among them ... 1.  Age-Driven Growth - True Impact Moment Arriving   ... the growing population and, to a more extreme extent, the ...
Breaking Medicine Technology: